ASELAGE STEVE received a stock award from BIOCRYST PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2023ACC: 0001127602-23-018786
+55.82K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
55.82K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.75K
Price / share
—
Trade value
—
% of position
35.9%
6/13/2023
46.59K→63.34K
Total
Net shares
+16.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2023 | A · Award | +16.75K | — | — | 35.9% | 46.59K | 63.34K |
| Total | +16.75K | $0.00 | ||||||
Derivative Transactions1
Automatic Stock Option Grant
Direct
Converts to
Common Stock
39.07K shares
Shares
+39.07K
Strike price
8.18
Held after
39.07K
Exercisable
—
6/13/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Automatic Stock Option Grant Direct | Common Stock39.07K shares | 6/13/2023 | A · Award | +39.07K | 8.18 | — | 39.07K |